Aprepitant

Welcome to Dwaey, specifically on Aprepitant page.
This medicine contains important and useful components, as it consists of
Aprepitant is available in the market in concentration.

Generic Name of Aprepitant - Learn More

Aprepitant

Aprepitant Precaution - What You Need to Know

Before using Aprepitant, it is essential to consult a healthcare provider to ensure it is safe and appropriate for your specific condition. Aprepitant is commonly used for nausea and vomiting caused by chemotherapy, and it can also be prescribed to prevent post-surgery nausea. There are some important precautions to be aware of:

- Liver Impairment: Aprepitant is metabolized in the liver, and patients with liver disease, particularly moderate to severe impairment, should use caution. Dose adjustments may be necessary, and liver function should be monitored.
- Drug Interactions: Aprepitant can interact with other medications, especially those that are metabolized by the CYP3A4 enzyme. These interactions can affect the efficacy or toxicity of other drugs. It is crucial to inform the healthcare provider of all medications being taken, including prescription, over-the-counter, and herbal products.
- Pregnancy and Breastfeeding: Aprepitant is classified as a Category B drug for pregnancy, meaning it is generally considered safe but should only be used if the potential benefits outweigh the risks. It is unknown whether it passes into breast milk, so caution should be exercised during breastfeeding, and it is recommended to consult a doctor.
- Allergic Reactions: If any signs of an allergic reaction occur, such as skin rash, swelling, or difficulty breathing, medical attention should be sought immediately. Though rare, severe allergic reactions can occur.
- Use in Children: Aprepitant should be used cautiously in children, and dosing may need to be adjusted based on age and weight.

Aprepitant Indication - Uses and Benefits

Aprepitant is primarily prescribed to prevent and treat nausea and vomiting, particularly in the following situations:

- Chemotherapy-Induced Nausea and Vomiting (CINV): Aprepitant is commonly used in combination with other antiemetic medications to prevent nausea and vomiting caused by chemotherapy, especially with highly emetogenic (vomit-inducing) drugs.
- Postoperative Nausea and Vomiting (PONV): Aprepitant is used to prevent nausea and vomiting that may occur after surgery. It is often administered as part of a multimodal antiemetic regimen.
- Other Indications: While its most common use is for chemotherapy and surgery-related nausea, Aprepitant may also be used off-label in certain situations to manage nausea in patients with other causes, but this is less frequent.

Aprepitant Contraindications - Important Warnings

Aprepitant should not be used in the following circumstances:

- Hypersensitivity: Aprepitant is contraindicated in patients with a known hypersensitivity or allergy to the drug or its ingredients.
- Severe Liver Impairment: Aprepitant is metabolized by the liver, and patients with severe hepatic impairment should not use this drug without careful consideration and possible dose adjustment.
- Concurrent Use with Certain Medications: Aprepitant may have dangerous interactions with certain medications, such as certain antifungals (e.g., ketoconazole), HIV protease inhibitors (e.g., ritonavir), and some antiarrhythmic drugs (e.g., quinidine). It should not be used with these drugs unless directed by a healthcare provider.
- Pregnancy (in high doses): Aprepitant should be avoided during pregnancy, especially in higher doses unless the benefits outweigh the risks, and only under strict medical supervision.

Aprepitant Side Effects - What to Expect

Common side effects of Aprepitant are typically mild but can include:

- Fatigue: A feeling of tiredness or drowsiness is commonly reported. This can interfere with daily activities and should be noted.
- Hiccups: In some cases, Aprepitant can cause hiccups, although this side effect is rare.
- Dizziness or Lightheadedness: Some people may feel dizzy when standing up, which can lead to falls or fainting in rare cases.
- Constipation: Aprepitant can cause digestive issues, including constipation, which may affect comfort and normal bowel movements.
- Headache: Another common side effect, though generally mild and short-lived.
- More Serious Side Effects:
- Severe Allergic Reactions: Signs include rash, swelling, or trouble breathing.
- Liver Issues: Signs of liver problems, such as yellowing of the skin or eyes (jaundice), dark urine, or abdominal pain, should be reported immediately.
- Low White Blood Cell Count: Rarely, Aprepitant may lead to low white blood cell counts, which can increase the risk of infection.

Aprepitant Pregnancy Category ID - Safety Information

2

Aprepitant Mode of Action - How It Works

Aprepitant works as an NK1 receptor antagonist, targeting the neurokinin-1 (NK1) receptor in the brain. NK1 receptors are involved in the transmission of signals related to nausea and vomiting. By blocking these receptors, Aprepitant helps to prevent the nausea and vomiting reflex that is triggered by chemotherapy, surgery, and other stimuli.

- Prevention of Nausea and Vomiting: By inhibiting NK1, Aprepitant reduces the effect of substance P (a neuropeptide that plays a role in nausea), providing effective relief from chemotherapy-induced and postoperative nausea.
- Combination with Other Medications: It is often used in combination with other antiemetic medications (like serotonin receptor antagonists) to provide a more comprehensive approach to managing nausea and vomiting.

Aprepitant Drug Interactions - What to Avoid

Aprepitant has significant interactions with other medications due to its effects on the liver enzyme CYP3A4. Some important interactions include:

- CYP3A4 Inhibitors and Inducers: Aprepitant can either enhance or reduce the effects of drugs metabolized by CYP3A4. For example, it can increase the levels of certain drugs (e.g., midazolam, cyclosporine) and decrease the levels of others (e.g., warfarin, oral contraceptives).
- Warfarin: Aprepitant may reduce the anticoagulant effect of warfarin. It is crucial to monitor prothrombin time (PT) and international normalized ratio (INR) closely when these drugs are co-administered.
- Oral Contraceptives: Aprepitant can reduce the effectiveness of oral contraceptives due to its enzyme-modulating effect. Alternative or additional contraception should be considered during treatment.
- Corticosteroids: Aprepitant can alter the effect of corticosteroids such as dexamethasone. Doses may need adjustment when co-administered.
- Other Medications: Always inform the healthcare provider about all medications, including over-the-counter drugs and herbal supplements, as interactions can occur with a wide range of substances.

Aprepitant Adult Dose - Recommended Dosage

The typical dose for Aprepitant in adults for chemotherapy-induced nausea and vomiting (CINV) is:

- Chemotherapy: Aprepitant is usually given as part of a combination therapy with other antiemetics (such as ondansetron or dexamethasone). The usual starting dose is 125 mg on the day of chemotherapy, followed by 80 mg daily for the next two days.
- Postoperative Nausea and Vomiting (PONV): The usual dose is 40 mg taken orally one hour before anesthesia induction.

It is important to follow the specific dosing regimen prescribed by the healthcare provider for each individual patient and situation.

Aprepitant Child Dose - Dosage for Children

For pediatric patients (aged 6 to 17 years) receiving chemotherapy:

- Chemotherapy-induced nausea and vomiting: Aprepitant is usually dosed based on weight. The typical dose is:
- 3-11 years: 3 mg/kg on day 1, followed by 2 mg/kg on days 2 and 3.
- 12 years and older: 125 mg on day 1, followed by 80 mg on days 2 and 3.

For postoperative nausea and vomiting, the safety and efficacy of Aprepitant in children under the age of 12 have not been established, and it should only be used if prescribed by a healthcare provider.

As always, dosing should be adjusted based on individual patient needs and medical guidance.

Aprepitant Renal Dose - Dosage for Kidney Conditions

Aprepitant is metabolized in the liver and primarily eliminated through bile. There is no specific dose adjustment required for patients with mild renal impairment (e.g., creatinine clearance ≥ 30 mL/min). However, for severe renal impairment (e.g., creatinine clearance < 30 mL/min), Aprepitant should be used with caution, and close monitoring is recommended due to potential alterations in drug metabolism or side effects.